Phio Historical Cash Flow
| PHIO Stock | USD 0.77 0.01 1.28% |
Analysis of Phio Pharmaceuticals cash flow over time is an excellent tool to project Phio Pharmaceuticals Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 4.8 K or Total Cash From Financing Activities of 9.8 M as it is a great indicator of Phio Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Phio Pharmaceuticals Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Phio Pharmaceuticals Corp is a good buy for the upcoming year.
Phio |
About Phio Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Phio balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Phio's non-liquid assets can be easily converted into cash.
Phio Pharmaceuticals Cash Flow Chart
Phio Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Phio Pharmaceuticals Corp Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Phio Pharmaceuticals' Change To Netincome is very stable compared to the past year. As of the 23rd of May 2024, Change To Operating Activities is likely to grow to about 1.7 M, though Change In Cash is likely to grow to (3.2 M). Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Phio Pharmaceuticals Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Phio Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Phio Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Phio Pharmaceuticals Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Phio Pharmaceuticals' Change To Netincome is very stable compared to the past year. As of the 23rd of May 2024, Change To Operating Activities is likely to grow to about 1.7 M, though Change In Cash is likely to grow to (3.2 M).
Phio Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Phio Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phio Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (7.9M) | 7.3M | 9.8M | (12.3M) | (3.3M) | (3.2M) | |
| Stock Based Compensation | 300K | 136K | 480K | 414K | 303K | 287.9K | |
| Free Cash Flow | (8.7M) | (8.8M) | (11.9M) | (12.3M) | (10.8M) | (11.3M) | |
| Change In Working Capital | (213K) | (327K) | 990K | (1.3M) | (536K) | (509.2K) | |
| Begin Period Cash Flow | 14.9M | 7.0M | 14.3M | 24.1M | 11.8M | 10.7M | |
| Other Cashflows From Financing Activities | (3K) | 8.2M | 2.1M | 2.0K | (37K) | (35.2K) | |
| Depreciation | 67K | 72K | 75K | 193K | 184K | 115.8K | |
| Other Non Cash Items | 109K | 111K | 117K | 304K | 4K | 3.8K | |
| Capital Expenditures | 5K | 72K | 19K | 51K | 121K | 4.8K | |
| Total Cash From Operating Activities | (8.6M) | (8.8M) | (11.9M) | (12.1M) | (10.7M) | (11.3M) | |
| Net Income | (8.9M) | (8.8M) | (13.3M) | (11.5M) | (10.8M) | (11.4M) | |
| Total Cash From Financing Activities | 772K | 16.1M | 21.7M | (26K) | 7.4M | 9.8M | |
| End Period Cash Flow | 7.0M | 14.3M | 24.1M | 11.8M | 8.5M | 10.8M | |
| Total Cashflows From Investing Activities | (5K) | (72K) | (19K) | (51K) | (58.7K) | (61.6K) | |
| Sale Purchase Of Stock | 1K | (15K) | (1.0) | (28.0) | (2K) | (1.9K) | |
| Investments | (5K) | (72K) | (19K) | (51K) | (121K) | (5.3K) | |
| Cash And Cash Equivalents Changes | (9.3M) | 11.3M | (7.9M) | 7.3M | 8.4M | 8.8M | |
| Cash Flows Other Operating | 4.7M | (2K) | (215K) | (550K) | (495K) | (470.3K) | |
| Change To Netincome | 282K | 409K | 247K | 364K | 327.6K | 542.3K | |
| Change To Liabilities | (521K) | 2K | (81K) | (445K) | (400.5K) | (380.5K) | |
| Change To Operating Activities | (562K) | (472K) | (246K) | 1.4M | 1.7M | 1.7M | |
| Issuance Of Capital Stock | 781K | 12.1M | 19.6M | 2K | 5.1M | 7.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Phio Stock analysis
When running Phio Pharmaceuticals' price analysis, check to measure Phio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phio Pharmaceuticals is operating at the current time. Most of Phio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Phio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.20) | Return On Assets (0.60) | Return On Equity (1.17) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.